Biotechnology/Chemical/Pharmaceutical Customer Partnership
Tuesday March 7th, 2006
United States Patent and Trademark Office
Remsen Building, Lobby Conference Room
400 Dulany Street
Alexandria, Virginia
The most recent quarterly meeting for the Biotechnology and Chemical Pharmaceutical Customer Partnership was held on November 10 th , 2005 at the U.S. Patent and Trademark Office. The Biotechnology and Chemical Pharmaceutical Customer Partnership is designed and developed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus. Invitations to participate will indicate that individual opinions are sought, rather than a group consensus and that the meetings are intended to be informal in nature and have varying participants. These customer partnership groups are formed with full recognition of the USPTO's responsibility under the Federal Advisory Committee Act (FACA), and that these customer partnership groups are not established as FACA compliant committees.
We value our customers in obtaining feedback from individual participants is important in our efforts to continuously improve the quality of our products and services. Your willing participation is helpful in providing us with insights and experiences in this informal process to assist us.
Please contact Cecilia Tsang at 571-272-0562, or by fax at 571-273-0562, or email Cecilia.Tsang@uspto.gov to decline or confirm your attendance by March 1st, 2006.
|
|
Morning Session |
9:00-9:15 |
Greetings and Overview |
John LeGuyader, Bruce Kisliuk,
George Elliott, Directors,
Technology Center 1600
|
9:15-10:00 |
EFS-web update |
Stew Levy, Deputy Commissioner
for Patent Resources and Planning Don Levin, Manager, eCommerce Unit
|
10:00-10:15 |
Break |
|
10:15-11:00 |
Patent Training Academy update |
Janice Falcone, Director Technology Center 2800
|
11:00-11:45 |
Proposed Rules Package Update |
John Doll, Commissioner for Patents
|
|
|
|
Afternoon Session |
|
|
|
11:45-1:00
|
Lunch |
|
1:00-1:45 |
New 101 training and examples |
Ardin Marschel, Supervisory Patent Examiner, Art Unit 1631 |
1:45-2:30 |
Baird/Ochiai |
Sreeni Padmanabhan, Supervisory Patent Examiner, Art Unit 1617 |
2:30-2:45 |
Break |
|
2:45-3:30 |
Antibody case law and practice |
Larry Helms, Supervisory Patent Examiner, Art Unit 1643 |
3:30-3:45 |
Closing Remarks/Discussion |
John LeGuyader, Bruce Kisliuk, George Elliott, Directors, TC 1600 |
|
|